This company has been acquired
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Societal CDMO Gestion
Gestion contrôle des critères 2/4
Societal CDMO's CEO is J. Enloe, appointed in Dec 2020, has a tenure of 3.33 years. total yearly compensation is $2.27M, comprised of 25.2% salary and 74.8% bonuses, including company stock and options. directly owns 0.76% of the company’s shares, worth $881.75K. The average tenure of the management team and the board of directors is 2.5 years and 3.3 years respectively.
Informations clés
J. Enloe
Directeur général
US$2.3m
Rémunération totale
Pourcentage du salaire du PDG | 25.2% |
Durée du mandat du directeur général | 3.3yrs |
Propriété du PDG | 0.8% |
Durée moyenne d'occupation des postes de direction | 2.5yrs |
Durée moyenne du mandat des membres du conseil d'administration | 3.3yrs |
Mises à jour récentes de la gestion
Recent updates
Societal CDMO, Inc.'s (NASDAQ:SCTL) Price Is Right But Growth Is Lacking After Shares Rocket 38%
Feb 10Is There An Opportunity With Societal CDMO, Inc.'s (NASDAQ:SCTL) 46% Undervaluation?
Feb 02Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?
Dec 23Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?
May 31Societal CDMO signs two CDMO service agreements
Oct 20Societal stock soars 20% on signing 2 manufacturing contracts
Sep 07Societal CDMO estimates to receive up to $50M on real estates' sales
Aug 16Societal CDMO, Lannett amend license and supply deal
Jul 12These 4 Measures Indicate That Societal CDMO (NASDAQ:SCTL) Is Using Debt Extensively
Apr 29Is Recro Pharma (NASDAQ:REPH) A Risky Investment?
Jan 06Recro Pharma jumps 15% on Q1 result estimates beat
May 07Would Shareholders Who Purchased Recro Pharma's (NASDAQ:REPH) Stock Year Be Happy With The Share price Today?
Feb 15Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$13m |
Sep 30 2023 | n/a | n/a | -US$22m |
Jun 30 2023 | n/a | n/a | -US$20m |
Mar 31 2023 | n/a | n/a | -US$20m |
Dec 31 2022 | US$2m | US$572k | -US$20m |
Sep 30 2022 | n/a | n/a | -US$13m |
Jun 30 2022 | n/a | n/a | -US$13m |
Mar 31 2022 | n/a | n/a | -US$9m |
Dec 31 2021 | US$1m | US$550k | -US$11m |
Sep 30 2021 | n/a | n/a | -US$21m |
Jun 30 2021 | n/a | n/a | -US$19m |
Mar 31 2021 | n/a | n/a | -US$27m |
Dec 31 2020 | US$1m | US$11k | -US$28m |
Rémunération vs marché: J.'s total compensation ($USD2.27M) is above average for companies of similar size in the US market ($USD662.77K).
Rémunération et revenus: J.'s compensation has increased whilst the company is unprofitable.
PDG
J. Enloe (59 yo)
3.3yrs
Titularisation
US$2,271,540
Compensation
Mr. J. David Enloe, Jr., serves as President, Chief Executive Officer and Director at Societal CDMO, Inc. (formerly known as Recro Pharma, Inc.) since December 16, 2020. Mr. Enloe had been the Chief Execut...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Executive Chairman of the Board | 16.3yrs | US$219.89k | 0.22% $ 258.5k | |
President | 3.3yrs | US$2.27m | 0.76% $ 881.8k | |
Senior VP & CFO | 6.3yrs | US$1.42m | 0.49% $ 575.0k | |
Senior VP & COO | 1.9yrs | pas de données | pas de données | |
Senior VP & Chief Scientific Officer | no data | pas de données | pas de données | |
Vice President of Sales | 2.3yrs | pas de données | pas de données | |
Senior VP & Chief People Officer | 2.8yrs | pas de données | pas de données |
2.5yrs
Durée moyenne de l'emploi
59yo
Âge moyen
Gestion expérimentée: SCTL's management team is considered experienced (2.5 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
Executive Chairman of the Board | 16.3yrs | US$219.89k | 0.22% $ 258.5k | |
President | 3.3yrs | US$2.27m | 0.76% $ 881.8k | |
Independent Director | 16.3yrs | US$192.39k | 0.22% $ 250.8k | |
Director | less than a year | pas de données | 0.60% $ 698.5k | |
Independent Director | 15.3yrs | US$194.89k | 0.18% $ 209.0k | |
Independent Director | 2.8yrs | US$189.89k | 0% $ 0 | |
Independent Director | 7.1yrs | US$194.89k | 0.21% $ 239.2k | |
Independent Director | 3.2yrs | US$192.39k | 0.15% $ 169.3k | |
Independent Director | 1.6yrs | US$30.80k | 0.028% $ 33.0k |
3.3yrs
Durée moyenne de l'emploi
64yo
Âge moyen
Conseil d'administration expérimenté: SCTL's board of directors are considered experienced (3.3 years average tenure).